Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | UGT2B7 | P16662 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13839652 | 1.00 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL10596591 | 1.00 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL15184686 | 1.00 | TP53 (0.52) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL15769664 | 0.88 | — | — | |
| SCHEMBL10768301 | 0.84 | TP53 (0.39) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL13839690 | 0.84 | TP53 (0.45) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL3886854 | 0.84 | TP53 (0.45) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL13839704 | 0.84 | TP53 (0.45) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL15013766 | 0.79 | TP53 (0.54) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL19276892 | 0.78 | UGT2B7 (0.33) | TP53UGT2B7IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113881442-B | Liquid crystal compound containing polyfluornonaphthalene and preparation method thereof | 宁夏中星显示材料有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-113881442-A | Liquid crystal compound containing polyfluornonaphthalene and preparation method thereof | 宁夏中星显示材料有限公司 | 2022-01-04 | — | — | CN | claimed |
| EP-3303534-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | P2 Science, Inc. (US) | 2018-04-11 | — | — | EP | claimed |
| WO-2016197000-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | P2 SCIENCE, INC. (US) | 2016-12-08 | — | — | WO | claimed |
| CN-111303908-B | Preparation method of dialkyl dicyclohexyl liquid crystal compound | 乌海瑞森新能源材料有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-113881442-B | Liquid crystal compound containing polyfluornonaphthalene and preparation method thereof | 宁夏中星显示材料有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-113881442-A | Liquid crystal compound containing polyfluornonaphthalene and preparation method thereof | 宁夏中星显示材料有限公司 | 2022-01-04 | — | — | CN | disclosed |
| US-10907116-B2 | Olfactive compositions comprising cyclohexyl-alkyl carbinols | P2 SCIENCE, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| CN-111303908-A | Preparation method of dialkyl dicyclohexyl liquid crystal compound | 华知(烟台)智能科技有限公司 | 2020-06-19 | — | — | CN | disclosed |
| US-20180163158-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | P2 SCIENCE, INC. | 2018-06-14 | — | — | US | disclosed |
| EP-3303534-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | P2 Science, Inc. (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-3303534-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | P2 Science, Inc. (US) | 2018-04-11 | — | — | EP | disclosed |
| US-6331650-B1 | Method for manufacturing aminoalcohol | KURARAY CO., LTD. (JP) | 2001-12-18 | — | — | US | disclosed |
| WO-2000065801-A9 | CYCLOHEXYL- AND CYCLOHEXENYL-SUBSTITUTED LIQUID CRYSTALS WITH LOW BIREFRINGENCE | DISPLAYTECH INC (US) | 2001-04-12 | — | — | WO | disclosed |
| EP-1074541-A1 | Method for manufacturing aminoalcohol | Kuraray Co., Ltd., Kurashiki Plant (JP) | 2001-02-07 | — | — | EP | disclosed |
| WO-2000065801-A1 | CYCLOHEXYL- AND CYCLOHEXENYL-SUBSTITUTED LIQUID CRYSTALS WITH LOW BIREFRINGENCE | DISPLAYTECH, INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| CN-1105984-A | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO CO (JP) | 1995-08-02 | — | — | CN | disclosed |
| US-4225470-A | Cyclohexane alkyl carbinol perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-09-30 | — | — | US | disclosed |
| US-4089897-A | Geminal prostaglandin analogs | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-05-16 | — | — | US | disclosed |
| US-4090019-A | Geminal prostaglandin analogs | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180163158-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | ACMSD, TAS2R1, MINK1 | TP53 4177/4885KDM4E 683/4885GMNN 2302/4885 |
| US-10907116-B2 | Olfactive compositions comprising cyclohexyl-alkyl carbinols | ACMSD, TAS2R1, MINK1 | TP53 4177/4885KDM4E 683/4885GMNN 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.